Queen's University Belfast
This sponsor has funded 1 studies across 1 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 1863 | Planned | Commonly prescribed drugs and association with breast, colorectal and lung cancer progression: a nested case-control study | Yes | No |
PAS by Risk Management Plan (RMP) requirement
Queen's University Belfast
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
Queen's University Belfast
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
Queen's University Belfast
1 Study countries specified are the following:
- United Kingdom